Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | RBP4 | P02753 | 1/20 | 0.37 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.37 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.37 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.35 |
| ▸ | LIPE | Q05469 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30038787 | 1.00 | ALDH1A1 (0.52) | ALDH1A1TSHRTDP1CA2ENPP2 | |
| SCHEMBL1507181 | 0.93 | TDP1 (0.46) | ALDH1A1TSHRTDP1CA2ENPP2 | |
| SCHEMBL3426499 | 0.93 | ALDH1A1 (0.46) | ALDH1A1TSHRTDP1CA2ENPP2 | |
| SCHEMBL28107367 | 0.84 | ENPP2 (0.71) | ALDH1A1TSHRTDP1CA2ENPP2 | |
| SCHEMBL15011081 | 0.83 | ENPP2 (0.41) | ALDH1A1TSHRTDP1CA2ENPP2 | |
| SCHEMBL3419277 | 0.82 | ENPP2 (0.43) | ALDH1A1TSHRTDP1CA2ENPP2 | |
| SCHEMBL6048537 | 0.81 | ENPP2 (0.40) | ALDH1A1TSHRTDP1CA2ENPP2 | |
| SCHEMBL20975383 | 0.81 | ENPP2 (0.40) | ALDH1A1TSHRTDP1CA2ENPP2 | |
| SCHEMBL31360869 | 0.79 | CA2 (0.48) | ALDH1A1TSHRTDP1CA2ENPP2 | |
| SCHEMBL28107366 | 0.79 | ENPP2 (0.37) | ALDH1A1TSHRTDP1CA2ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005471-A | Novel method for synthesizing 4-tert-butyl biphenyl by using palladium to catalyze tetrafluorothianthrene salt | 内蒙古大学 | 2024-05-10 | — | — | CN | claimed |
| CN-110523354-A | A kind of preparation method of the microreactor containing solid-carried catalyst | UNIV ZHEJIANG | 2019-12-03 | — | — | CN | claimed |
| CN-109134342-A | The high efficiency preparation method of one kind 3,4- disubstituted pyrroles | 大连理工大学 | 2019-01-04 | — | — | CN | claimed |
| CN-108794518-A | It is a kind of using BODIPY as organic conjugated molecule material of basic framework and preparation method thereof | 安徽师范大学 | 2018-11-13 | — | — | CN | claimed |
| CN-105198690-B | The preparation method of the various positions substitution compound of fluorene class of halogen regulation and control | 南京邮电大学 | 2017-11-14 | — | — | CN | claimed |
| CN-104844400-B | Preparation method for 9-fluorenone and T type oligomeric phenylene skeleton compounds | 南京邮电大学 | 2017-03-22 | — | — | CN | claimed |
| CN-106117256-A | β phenanthro-azepine fluorine boron two pyrylium dyes and its preparation method and application | 安徽师范大学 | 2016-11-16 | — | — | CN | claimed |
| CN-105732574-A | Preparation of thianthrene-5, 5,10, 10-tetraoxide derivative and organic electroluminescent device based on thianthrene-5, 5,10, 10-tetraoxide derivative | 中国科学院理化技术研究所 | 2016-07-06 | — | — | CN | claimed |
| CN-105693608-A | 2, 2-dimethyl-1, 3-indene dione derivatives and organic electroluminescent devices based thereon | 中国科学院理化技术研究所 | 2016-06-22 | — | — | CN | claimed |
| CN-105198690-A | Preparation method of all-position replacement fluorene compounds obtained through halogen adjustment and control | UNIV NANJING POSTS & TELECOMM | 2015-12-30 | — | — | CN | claimed |
| CN-104844400-A | Preparation method for 9-fluorenone and T type oligomeric phenylene skeleton compounds | UNIV NANJING POSTS & TELECOMM | 2015-08-19 | — | — | CN | claimed |
| CN-104498025-A | Polyphenyl benzene structured cyanogroup-containing luminescent molecule and preparation method and purpose thereof | UNIV WUHAN | 2015-04-08 | — | — | CN | claimed |
| US-12630566-B2 | KRas G12D inhibitors | Mirati Therapeutics, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| CN-122010899-A | Continuous flow preparation method of lenalidomide and derivatives thereof | 深圳连续制药科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12509480-B2 | Organometallic complex, light emitting diode, and electronic device | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-12-30 | — | — | US | disclosed |
| US-20250234703-A1 | Organic Compound And Organic Light-Emitting Element Comprising Same | P&H TECH CO., LTD (KR) | 2025-07-17 | — | — | US | disclosed |
| US-20030009046-A1 | Preparation of preparing substituted indanones | EQUISTAR CHEMICALS, LP | 2003-01-09 | — | — | US | disclosed |
| EP-1242434-A1 | POLYMERIZATION-ACTIVE TRANSITION METAL COMPLEX COMPOUNDS COMPRISING A STERICALLY DEMANDING LIGAND SYSTEM | BASF AKTIENGESELLSCHAFT (DE) | 2002-09-25 | — | — | EP | disclosed |
| EP-0832082-B1 | N-HETEROARYL-PYRIDINESULFONAMIDE DERIVATIVES AND THEIR USE AS ENDOTHELIN ANTAGONISTS | ASTRAZENECA AB (SE) | 2001-11-21 | — | — | EP | disclosed |
| WO-2001042257-A1 | POLYMERIZATION-ACTIVE TRANSITION METAL COMPLEX COMPOUNDS COMPRISING A STERICALLY DEMANDING LIGAND SYSTEM | BASF AKTIENGESELLSCHAFT (DE) | 2001-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630566-B2 | KRas G12D inhibitors | KRAS, NRAS, HRAS | ALDH1A1 1816/4885TSHR 4213/4885TDP1 3446/4885 |
| US-12509480-B2 | Organometallic complex, light emitting diode, and electronic device | GRK1, CRY1, NR2E3 | ALDH1A1 53/4885TSHR 2295/4885TDP1 2897/4885 |
| US-20250234703-A1 | Organic Compound And Organic Light-Emitting Element Comprising Same | CRY2, CRY1, RBP4 | ALDH1A1 584/4885TSHR 4594/4885TDP1 2470/4885 |
| US-20030009046-A1 | Preparation of preparing substituted indanones | CYP1A2, CYP1B1, CYP1A1 | ALDH1A1 198/4885TSHR 4667/4885TDP1 3321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.